More News
6 July 2021
Eureka Therapeutics Announces New GPRC5D License Agreement with Sanofi to Target Multiple Myeloma2 July 2021
Seres Therapeutics, Nestlé Health Science Announce SER-109 Co-Commercialization License Agreement29 June 2021
Ixaka and SomaLogic enter research collaboration to develop bispecific agents for oncology29 June 2021
Synaffix Licenses its Award-Winning ADC Technology in Deal Adding a New ADC to Innovent’s Pipeline24 June 2021
eTheRNA and VUB expand strategic collaboration to engineer next generation mRNA therapeutics with TetraMix®17 June 2021
Rancho Santa Fe Bio, Inc. Enters into Worldwide Exclusive License Agreement with Sanofi for Ataciguat10 June 2021
Bright Peak Therapeutics Announces $107 Million Series B Financing and Expanded Board of DirectorsNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports